WIM
TBPH icon

Woodford Investment Management’s Theravance Biopharma TBPH Stock Holding History

Woodford Investment Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,350,719
Closed -$221M – 2
2019
Q3 		$221M Sell
11,350,719
-809,261
-7% -$16.4M 71.3% 1
2019
Q2 		$199M Sell
12,159,980
-1,219,999
-9% -$24.7M 33.59% 1
2019
Q1 		$303M Buy
13,379,979
+1,063,450
+9% +$27M 24.48% 2
2018
Q4 		$315M Buy
12,316,529
+621,650
+5% +$16.8M 27.26% 2
2018
Q3 		$382M Buy
11,694,879
+481,000
+4% +$13.1M 30.43% 1
2018
Q2 		$254M Buy
11,213,879
+315,000
+3% +$7.48M 30.84% 1
2018
Q1 		$264M Buy
10,898,879
+151,771
+1% +$4.17M 23.51% 3
2017
Q4 		$300M Buy
10,747,108
+41,000
+0.4% +$1.21M 20.21% 3
2017
Q3 		$367M Sell
10,706,108
-72
-0% -$2.35K 16.83% 3
2017
Q2 		$427M Buy
10,706,180
+1,072
+0% +$41.2K 15.67% 4
2017
Q1 		$394M Buy
10,705,108
+197,500
+2% +$6.31M 16.31% 4
2016
Q4 		$335M Buy
10,507,608
+1,100,471
+12% +$34.1M 16.13% 4
2016
Q3 		$341M Buy
9,407,137
+673,500
+8% +$18.8M 13.78% 5
2016
Q2 		$198M Buy
8,733,637
+1,909,000
+28% +$41.2M 9.31% 5
2016
Q1 		$128M Buy
6,824,637
+1,763,000
+35% +$28.8M 5.86% 5
2015
Q4 		$83M Buy
5,061,637
+4,700,952
+1,303% +$74.6M 3.56% 5
2015
Q3 		$3.96M Buy
+360,685
New +$4.59M 0.23% 6

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LFS
Link Fund Solutions London, United Kingdom $157M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Woodford Investment Management's TBPH Position: Q4 2019 in Review

Woodford Investment Management sold out of Theravance Biopharma (TBPH) in Q4 2019, closing a stake of 11,350,719 shares — an estimated $221M sold.

Woodford Investment Management first reported a position in TBPH in Q3 2015 and held it in 17 quarters. The position peaked at $427M in Q2 2017. 108 funds tracked by Wall St. Rank hold TBPH as of Q4 2019.

  • Woodford Investment Management reported no remaining Theravance Biopharma position as of Q4 2019 after selling out during the quarter.
  • Woodford Investment Management sold 11,350,719 Theravance Biopharma shares in Q4 2019, an estimated $221M.
  • Woodford Investment Management first reported a position in Theravance Biopharma in Q3 2015 and held it in 17 quarters.
  • Woodford Investment Management's Theravance Biopharma position peaked at $427M in Q2 2017.
  • 108 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2019.

Based on Woodford Investment Management's 13F filing for Q4 2019.